Mice Develop Effective but Delayed Protective Immune Responses When Immunized as Neonates either Intranasally with Nonliving VP6/LT(R192G) or Orally with Live Rhesus Rotavirus Vaccine Candidates
暂无分享,去创建一个
R. Ward | J. Bean | J. Clements | M. McNeal | M. Basu | A. Choi | J. Vancott | A. Prada | S. Stone | Bert Huffer | K. Smiley | M. Shao
[1] R. Ward,et al. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. , 2006, Virology.
[2] J. Heyse,et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.
[3] T. Vesikari,et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.
[4] J. Shellito,et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae , 2005, The Journal of experimental medicine.
[5] C. Mason,et al. Pulmonary Interleukin-23 Gene Delivery Increases Local T-Cell Immunity and Controls Growth of Mycobacterium tuberculosis in the Lungs , 2005, Infection and Immunity.
[6] P. Lambert,et al. Can successful vaccines teach us how to induce efficient protective immune responses? , 2005, Nature Medicine.
[7] E. Butcher,et al. Chapter 34 – Lymphocyte Homing: Chemokines and Adhesion Molecules in T cell and IgA Plasma Cell Localization in the Mucosal Immune System , 2005 .
[8] J. Bienenstock,et al. Chapter 20 – Bronchus-Associated Lymphoid Tissues , 2005 .
[9] M. G. Ferrari,et al. Mucosal adjuvants. , 2005, Current pharmaceutical design.
[10] R. Ward,et al. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice. , 2004, Protein expression and purification.
[11] T. Vesikari,et al. A Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus Gastroenteritis , 2004, The Pediatric infectious disease journal.
[12] A. Lindén,et al. Interleukin-17 family members and inflammation. , 2004, Immunity.
[13] C. Leclerc,et al. Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.
[14] B. Adkins,et al. Murine Neonatal Lymphocytes Show Rapid Early Cell Cycle Entry and Cell Division1 , 2003, The Journal of Immunology.
[15] Mark A. Miller,et al. Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.
[16] P. Lambert,et al. Unresponsiveness to Lymphoid-Mediated Signals at the Neonatal Follicular Dendritic Cell Precursor Level Contributes to Delayed Germinal Center Induction and Limitations of Neonatal Antibody Responses to T-Dependent Antigens 1 , 2003, The Journal of Immunology.
[17] R. Ward,et al. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. , 2002, Vaccine.
[18] H. Greenberg,et al. Heterologous Protection Induced by the Inner Capsid Proteins of Rotavirus Requires Transcytosis of Mucosal Immunoglobulins , 2002, Journal of Virology.
[19] B. Prasad,et al. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. , 2002, The Journal of clinical investigation.
[20] C. Pénit,et al. Naive T cells proliferate strongly in neonatal mice in response to self-peptide/self-MHC complexes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Ward,et al. CD4 T Cells Are the Only Lymphocytes Needed To Protect Mice against Rotavirus Shedding after Intranasal Immunization with a Chimeric VP6 Protein and the Adjuvant LT(R192G) , 2002, Journal of Virology.
[22] C. Siegrist. Neonatal and early life vaccinology. , 2001, Vaccine.
[23] Alan D. Roberts,et al. Protection from Respiratory Virus Infections Can Be Mediated by Antigen-Specific Cd4+ T Cells That Persist in the Lungs , 2001, The Journal of experimental medicine.
[24] R. Ward,et al. Functional Mapping of Protective Domains and Epitopes in the Rotavirus VP6 Protein , 2000, Journal of Virology.
[25] R. Glass,et al. Serum antibody as a marker of protection against natural rotavirus infection and disease. , 2000, The Journal of infectious diseases.
[26] H. Friess,et al. IL-17 Stimulates Intraperitoneal Neutrophil Infiltration Through the Release of GROα Chemokine from Mesothelial Cells1 , 2000, The Journal of Immunology.
[27] M. Estes,et al. Intranasal Administration of 2/6-Rotavirus-Like Particles with Mutant Escherichia coli Heat-Labile Toxin (LT-R192G) Induces Antibody-Secreting Cell Responses but Not Protective Immunity in Gnotobiotic Pigs , 2000, Journal of Virology.
[28] Y. Umesaki,et al. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. , 2000, Microbes and infection.
[29] J. Bonnefoy,et al. CD4+ T-Cell-Mediated Antiviral Protection of the Upper Respiratory Tract in BALB/c Mice following Parenteral Immunization with a Recombinant Respiratory Syncytial Virus G Protein Fragment , 2000, Journal of Virology.
[30] B. Adkins. Development of Neonatal Th1/Th2 Function , 2000, International reviews of immunology.
[31] C. Siegrist. Vaccination in the Neonatal Period and Early Infancy , 2000, International reviews of immunology.
[32] M. Sarzotti,et al. T cell immunity in neonates , 2000, Immunologic research.
[33] R. Ward,et al. Antibody-Independent Protection against Rotavirus Infection of Mice Stimulated by Intranasal Immunization with Chimeric VP4 or VP6 Protein , 1999, Journal of Virology.
[34] R. Ward,et al. Antibody-Dependent and -Independent Protection following Intranasal Immunization of Mice with Rotavirus Particles , 1999, Journal of Virology.
[35] J. Cebra,et al. Influences of microbiota on intestinal immune system development. , 1999, The American journal of clinical nutrition.
[36] P. Doherty,et al. CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Banchereau,et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. , 1998, Journal of the American Society of Nephrology : JASN.
[38] D. Brooks,et al. Critical Role for CD4+ T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice , 1998, Journal of Virology.
[39] M. Estes,et al. Rotavirus 2/6 Viruslike Particles Administered Intranasally with Cholera Toxin, Escherichia coli Heat-Labile Toxin (LT), and LT-R192G Induce Protection from Rotavirus Challenge , 1998, Journal of Virology.
[40] R. Ward,et al. Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities , 1997, Journal of virology.
[41] M. Estes,et al. Rotavirus virus-like particles administered mucosally induce protective immunity , 1997, Journal of virology.
[42] D. Bass,et al. Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines , 1997, Gastroenterology.
[43] R. Ward,et al. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. , 1997, Virology.
[44] H. Greenberg,et al. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model. , 1997, The Journal of infectious diseases.
[45] J. Seidman,et al. Lack of association of secretory component with IgA in J chain-deficient mice. , 1996, Journal of immunology.
[46] J. Banchereau,et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines , 1996, The Journal of experimental medicine.
[47] L. Saif,et al. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease , 1996, Journal of virology.
[48] L. Saif,et al. Development of mucosal and systemic lymphoproliferative responses and protective immunity to human group A rotaviruses in a gnotobiotic pig model , 1996, Clinical and diagnostic laboratory immunology.
[49] H. Greenberg,et al. Protective Effect of Rotavirus VP6-Specific IgA Monoclonal Antibodies That Lack Neutralizing Activity , 1996, Science.
[50] R. Ward,et al. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. , 1995, Virology.
[51] H. Greenberg,et al. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice , 1995, Journal of virology.
[52] R. Ward,et al. Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus. , 1995, Virology.
[53] B. Rouse,et al. Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells , 1995, Journal of virology.
[54] G. Splitter,et al. Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies , 1995, Journal of virology.
[55] J. Clements,et al. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity , 1995, Infection and immunity.
[56] H. Greenberg,et al. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus , 1994, Journal of virology.
[57] R. Ward,et al. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. , 1994, Virology.
[58] R. Glass,et al. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. , 1993, The Journal of infectious diseases.
[59] M. Estes,et al. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. , 1993, The Journal of infectious diseases.
[60] R. Ward,et al. Active protection against rotavirus infection of mice following intraperitoneal immunization. , 1992, Virology.
[61] G. Barnes,et al. Role of coproantibody in clinical protection of children during reinfection with rotavirus , 1992, Journal of clinical microbiology.
[62] R. Ward,et al. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. , 1992, Virology.
[63] L. Saif,et al. Prevention of Human Rotavirus-Induced Diarrhea in Gnotobiotic Piglets using Bovine Antibody , 1992, The Journal of infectious diseases.
[64] D. Sack,et al. Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. , 1992, The Journal of infectious diseases.
[65] R. Ward,et al. Development of an improved method for measuring neutralizing antibody to rotavirus. , 1991, Journal of virological methods.
[66] Gary J. Nabel,et al. New Generation Vaccines , 1990 .
[67] R. Ward,et al. Development of an adult mouse model for studies on protection against rotavirus. , 1990, Journal of virology.
[68] D. Bernstein,et al. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. , 1989, The Journal of infectious diseases.
[69] K. Taniguchi,et al. PROTECTIVE EFFECT OF NATURALLY ACQUIRED HOMOTYPIC AND HETEROTYPIC ROTAVIRUS ANTIBODIES , 1986, The Lancet.
[70] R. Feigin,et al. Textbook of Pediatric Infectious Diseases , 1986 .
[71] P. Offit,et al. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies , 1985, Journal of virology.
[72] J. Bienenstock. Bronchus-associated lymphoid tissue. , 1985, International archives of allergy and applied immunology.
[73] G. Barnes,et al. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. , 1983, The New England journal of medicine.
[74] A. Whitelaw,et al. Passive immunity in calf rotavirus infections: maternal vaccination increases and prolongs immunoglobulin G1 antibody secretion in milk , 1980, Infection and immunity.